| scholarly article | Q13442814 |
| P50 | author | John E Sims | Q55293020 |
| P2093 | author name string | Slack JL | |
| Dower SK | |||
| Giri JG | |||
| Arend WP | |||
| Malyak M | |||
| Smith MF Jr | |||
| Whisenand TD | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4766-4774 | |
| P577 | publication date | 1994-11-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids | |
| P478 | volume | 153 |
| Q71576582 | 3rd International Symposium on the Immunotherapy of the Rheumatic Diseases. 10-14 May 1995, Cyprus. Abstracts |
| Q77953405 | Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system |
| Q47762706 | Age-dependent decreases in serum soluble interleukin-1 receptor type I (sIL-1RI) in healthy individuals: a population study of serum sIL-1RI levels in Japanese subjects. |
| Q33762852 | Allosteric switching of agonist/antagonist activity by a single point mutation in the interluekin-1 receptor antagonist, IL-1Ra |
| Q36375747 | Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene |
| Q34052680 | Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors. |
| Q34071296 | Biological role of interleukin 1 receptor antagonist isoforms |
| Q35545187 | Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks |
| Q35126948 | C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis |
| Q34126507 | Contribution of interleukin-11 and prostaglandin(s) in lipopolysaccharide-induced bone resorption in vivo. |
| Q38920969 | Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation |
| Q36994635 | Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily |
| Q33643146 | Deficient spontaneous in vitro apoptosis and increased tmTNF reverse signaling-induced apoptosis of monocytes predict suboptimal therapeutic response of rheumatoid arthritis to TNF inhibition |
| Q27676526 | Design of a superior cytokine antagonist for topical ophthalmic use |
| Q36089320 | Differences of IL-1β Receptors Expression by Immunocompetent Cells Subsets in Rheumatoid Arthritis. |
| Q33774843 | Different Regulation of Interleukin-1 Production and Activity in Monocytes and Macrophages: Innate Memory as an Endogenous Mechanism of IL-1 Inhibition |
| Q36477567 | Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects |
| Q33523291 | Expression and function of TNF and IL-1 receptors on human regulatory T cells |
| Q54748749 | Human colon carcinomas constitutively express and shed type II IL-1 receptor, an IL-1 antagonist |
| Q49461527 | IL-1 family cytokines and soluble receptors in systemic lupus erythematosus |
| Q26826872 | IL-1 receptor 2 (IL-1R2) and its role in immune regulation |
| Q37370139 | Identification of functional endothelial protein C receptor in human plasma |
| Q60718581 | Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease |
| Q33355903 | Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. |
| Q39512878 | Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental Shigellosis |
| Q41838290 | Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function. |
| Q24310224 | Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein |
| Q64076510 | Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma |
| Q34427440 | Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome |
| Q35737149 | Interleukin-1β in Central Nervous System Injury and Repair. |
| Q39059671 | Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures |
| Q34074849 | Modulation of T cell proliferation and cytokine response by Plumbagin, extracted from Plumbago zeylanica in collagen induced arthritis |
| Q30417497 | Murine P-glycoprotein deficiency alters intestinal injury repair and blunts lipopolysaccharide-induced radioprotection |
| Q36994761 | Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease |
| Q33829027 | Plasma cytokines associated with febrile status epilepticus in children: A potential biomarker for acute hippocampal injury |
| Q37376059 | Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor. |
| Q28281545 | Regulation of serum amyloid A protein expression during the acute-phase response |
| Q36302597 | Relationship between interleukin-1 type 1 and 2 receptor gene polymorphisms and the expression level of membrane-bound receptors. |
| Q42266398 | Structural basis for IL-1α recognition by a modified DNA aptamer that specifically inhibits IL-1α signaling |
| Q24671672 | Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18 |
| Q35534719 | Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations |
| Q30951696 | Targeting interleukin 18 with interleukin 18 binding protein |
| Q21202840 | The generation and function of soluble apoE receptors in the CNS |
| Q36319606 | The use of anakinra in juvenile arthritis |
| Q41267810 | Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. |
| Q45890242 | Treatment of rheumatoid arthritis with IL-1 inhibitors |
| Q47285918 | Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8. |
| Q36564183 | White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution. |
Search more.